Researchers identify potential therapeutic target for alcohol-associated liver disease and alcohol use disorder

Scientists have identified a particular protein in the body that may influence the progression of alcohol-associated liver disease and drinking behavior. The protein aquaporin 9 (AQP9) helps liver cells absorb and excrete a byproduct of alcohol, which can be toxic to the body. The findings, published in Alcohol: Clinical and Experimental Research, point to AQP9 as a potential therapeutic target for the treatment of advanced liver disease and alcohol use disorder.